TrialJournal of acquired immune deficiency syndromes (1999)2015

HIV disease progression in seroconvertors from the CAPRISA 004 tenofovir gel pre-exposure prophylaxis trial.

Nigel J Garrett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.